A federal jury in Delaware said on Thursday that biotech company Amgen owes competitor Regeneron more than $406 million for ...

An international study led by Monash University has found that a new cholesterol-lowering drug called Obicetrapib could offer ...

Natural statins are dietary supplements known for their ability to lower cholesterol. Certain foods contain natural ...

Discover natural methods to lower your cholesterol, from plant sterols and Mediterranean eating to specific exercises that ...

In the long-running feud between Regeneron and Amgen around the companies’ competing PCSK9 cholesterol meds, Regeneron has eked out another legal win over its rival. | A federal jury in Delaware has ...

This superfood is crafted from a unique yeast that has a compound similar to that found in statin medications.

A Monash-led international study has found a cholesterol-lowering drug may offer a more effective and convenient way to protect people at high risk of heart attack and stroke. The clinical trial ...

Researchers have discovered a promising new drug combination that significantly lowers “bad” LDL cholesterol for people whose ...

The superfood is made with a specific yeast which contains a certain chemical that is the same as a statin medication ...

Family history of heart disease means you need lower cholesterol numbers. Discover the specific targets that can save your ...

Amgen Owes $406 Million for Monopolizing Cholesterol Drug Market, US Jury Says By Blake Brittain (Reuters) -A federal jury in Delaware said on Thursday that biotech company Amgen owes competitor ...

The jury agreed with Regeneron that Amgen unlawfully bundled Repatha with two of its blockbuster anti-inflammatory drugs to persuade pharmacy benefit managers to buy it instead of Praluent.